FEGOX
Price
$23.34
Change
+$0.14 (+0.60%)
Updated
Apr 19, 6:59 PM EST
FGDCX
Price
$21.23
Change
+$0.14 (+0.66%)
Updated
Apr 19, 6:59 PM EST
Ad is loading...

Analysis and predictions FEGOX vs FGDCX

Header iconFEGOX vs FGDCX Comparison
Open Charts FEGOX vs FGDCXBanner chart's image
First Eagle Gold C
Price$23.34
Change+$0.14 (+0.60%)
VolumeN/A
CapitalizationN/A
Fidelity Advisor Gold C
Price$21.23
Change+$0.14 (+0.66%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FEGOX vs FGDCX Comparison Chart

Loading...

VS
FEGOX vs. FGDCX commentary
Apr 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEGOX is a Buy and FGDCX is a StrongSell.

FUNDAMENTALS
Fundamentals
FEGOX has more cash in the bank: 2.4B vs. FGDCX (1.24B). FEGOX pays higher dividends than FGDCX: FEGOX (0.22) vs FGDCX (0.00). FEGOX was incepted earlier than FGDCX: FEGOX (21 years) vs FGDCX (17 years). FGDCX is a more actively managed with annual turnover of: 46.00 vs. FEGOX (16.39). FGDCX has a lower initial minimum investment than FEGOX: FGDCX (0) vs FEGOX (2500). FEGOX annual gain was more profitable for investors over the last year : 0.01 vs. FGDCX (-7.29). FEGOX return over 5 years is better than : 75.33 vs. FGDCX (35.58).
FEGOXFGDCXFEGOX / FGDCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years17 years-
Gain YTD7.0648.30785%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.4B1.24B194%
Annual Yield % from dividends0.220.00-
Returns for 1 year0.01-7.29-0%
Returns for 3 years3.34-16.94-20%
Returns for 5 years75.3335.58212%
Returns for 10 years47.7415.18314%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLFY8.430.41
+5.11%
Blue Foundry Bancorp
MTB143.384.08
+2.93%
M&T Bank Corp
OTTR84.251.96
+2.38%
Otter Tail Corp
SBR63.821.47
+2.36%
Sabine Royalty Trust
MEIP3.25N/A
N/A
MEI Pharma